CFP Board Promotes Public Trust With 4 ActionsUpholding Ethical Standards in a Thriving Network of Over 109,000 CFP® Professionals
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric ApprovalDANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that management will host a conference call to discuss the recent FDA approval of Afrezza® for use in children and adolescents aged 6 and older living with diabetes at 4:30 p.m. Eastern on Friday, May 29, 2026. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, PharmD and Kevin Kaiserman, MD, Senior Vice President, Therapeutic Area Head-Diabetes.
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer DrugsStreamlined approach could reduce time and cost to bring new cancer drugs into human trials
The Heat Came Early and the Grid Wasn’t Ready. Jackery Urges Families to Prepare for a Summer of Power UncertaintyAs a historic May heat wave triggers grid emergencies from DC to Philadelphia, and as AI data centers quietly reshape America’s grid, families are already feeling it. Here’s how to take back control before the heat peaks
GLOBAL Down Syndrome Foundation Celebrates Historic Bipartisan Advancement of the DeOndra Dixon INCLUDE Project ActHouse Energy & Commerce Committee Unanimously Advances Landmark Legislation as Congressional Leaders Honor DeOndra Dixon, John J. Sie, Michelle Sie Whitten, and GLOBAL's Decades of Advocacy
POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options
SES AI LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Urges SES AI Corporation Investors with Significant Losses to Contact the Firm Before June 26thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SES To Contact Him Directly To Discuss Their Options
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain ListingSINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it completed a reverse stock split on May 27, 2026, and requested a hearing before the Nasdaq Hearings Panel (the “Panel”), in response to a staff determination letter (the “Letter”) received on May 27, 2026, from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”). The Letter notified the Company that, due to the Company’s failure to regain compliance with a minimum bid price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”), Nasdaq has determined (the “Determination”) that Company’s securities will be scheduled for delisting from Nasdaq unless the Company requests an appeal of the Determination to a Panel.
NEW ERA ENERGY (NASDAQ:NUAI) DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds New Era Energy & Digital, Inc. Investors of the June 1st Deadline to Seek Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In New Era Energy (NUAI) To Contact Him Directly To Discuss Their Options
Shoptalk Connects Groceryshop and Shoptalk Fall, Announces Innovation WeekTwo cities, two flagship events. A combined 7,500 executives. A $250 ticket add-on gets attendees into both.
ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in New YorkBEVERLY, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- ATN International, Inc. (“ATN”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today announced that management will participate in the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square on June 11, 2026.
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with DiabetesDANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Afrezza® (insulin human) Inhalation Powder for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes.
Antichi Cammini d’Italia: the Italia.it app and smart signage automatically interact with users along the five routesA network of 60 smart devices installed along the five itineraries, equipped with proximity technology, connects with the Italia.it app: users receive push notifications on their smartphones, giving them immediate access to maps and multimedia content. An integral part of the “Antichi Cammini d’Italia” project.
Syncron and TrueContext Help Manufacturers Turn Field Execution into Better Warranty DecisionsIntegration connects mobile field workflows with warranty operations to improve data quality, service performance, and operational efficiency
Karat Packaging to Participate in Wells Fargo 16th Annual Global Industrials & Materials ConferenceCHINO, Calif, May 29, 2026 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (“Karat”), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced that Chief Executive Officer, Alan Yu, and Chief Financial Officer, Jian Guo, will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference on Thursday, June 11, 2026 at 12:45 pm CDT, taking place at the Loews Chicago Hotel. Management will conduct one-on-one meetings with investors during the conference.
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited (“Immutep” or “the Company”) (
NASDAQ: IMMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sportradar Group AG (“Sportradar” or “the Company”) (
NASDAQ: SRAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
CVLT Investors Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Commvault Systems, Inc. (“Commvault” or “the Company”) (
NASDAQ: CVLT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GPK Investors Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Graphic Packaging Holding Company (“Graphic Packaging” or “the Company”) (
NYSE: GPK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Ipsos announces the creation of an Advisory Board chaired by Eileen CampbellIpsos announces the creation of an Advisory Board chaired by Eileen Campbell
FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FS KKR Capital Corp. (“FSK” or “the Company”) (
NYSE: FSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against POET Technologies Inc. (“POET” or “the Company”) (
NASDAQ: POET) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SES AI Corporation (“SES” or “the Company”) (
NYSE: SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 29, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globant S.A. (“Globant” or “the Company”) (
NYSE: GLOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NordVPN redefines digital protection with a next-generation antivirus and advanced VPN in one appThe new direction reflects how online threats have evolved beyond malicious files to phishing, scams, identity theft, and account takeover
Roofing Reality Check: Risk Is Rising Even in Quiet Storm YearsHail volatility, aging roofs drive higher residential replacement severity, Verisk finds
Berger Montague PC Investigating Claims on Behalf of AeroVironment, Inc. (NASDAQ: AVAV) Investors After Class Action FilingPHILADELPHIA, May 29, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against AeroVironment, Inc. (
NASDAQ: AVAV) (“AeroVironment” or the “Company”) on behalf of investors who purchased or acquired AeroVironment common stock during the period from June 25, 2025 through March 10, 2026 (the “Class Period”).
Talkspace Stockholders Vote to Approve Acquisition by UHSNEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. (“Talkspace”) (Nasdaq: TALK) today announced that at the special meeting of Talkspace stockholders held on May 29, 2026, the Talkspace stockholders voted to approve the acquisition of Talkspace by Universal Health Services, Inc. (“UHS”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of March 9, 2026 (the “Merger Agreement”), by and among Talkspace, UHS and UHS Merger Subsidiary, Inc., an indirect wholly owned subsidiary of UHS.
GoldHaven Scales Up Its Hunt for the Next Big BC DiscoveryIssued on behalf of GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS)
NevGold Just Pulled 53.7% Antimony Off the Surface in NevadaIssued on behalf of NevGold Corp. (TSXV: NAU) (OTCQX: NAUFF) (Frankfurt: 5E50)
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-DevelopmentKUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a technology-focused company advancing innovation across biotechnology, precision diagnostics, and emerging healthcare platforms, today highlighted its participation in the 2026 China–Malaysia Economic Cooperation Outlook Forum, held on May 21, 2026 at the Mandarin Oriental Hotel in Kuala Lumpur.
Eagleview and Nearmap Reach Settlement in Patent DisputeRochester, NY, May 29, 2026 (GLOBE NEWSWIRE) -- Eagleview and Nearmap have reached a settlement resolving their litigation pending in the United States District Court for the District of Utah dating back to 2021. The parties have agreed to mutually acceptable terms that conclude a dispute relating primarily to roofing measurement patents and other intellectual property matters. The resolution brings the matter to a close and allows both companies to focus fully on their respective business priorities and customers. As part of the settlement, all pending disputes between the companies are resolved. The specific terms of the settlement are confidential.
WISeKey’s SEALCOIN Platform Confirms Integration of QAIT Token Following Market LaunchWISeKey’s SEALCOIN Platform Confirms Integration of QAIT Token Following Market Launch
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression TreatmentVancouver, Canada, May 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the publication of a Japanese Patent Application for its proprietary compositions comprising 5-Methoxy-2-aminoindan (MEAI) for the treatment of depression.
Global Water Resources Declares Monthly DividendPHOENIX, May 29, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (
NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in AustraliaUpdated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and MDMA
Ottawa Fleet Services, Ontario Achieves $14 Million in Online Surplus Sales on GovDealsMilestone reached through years of online surplus vehicle and industrial equipment auctions conducted on GovDeals
Heritage Distribution acquires AM DistributorsATLANTA, May 29, 2026 (GLOBE NEWSWIRE) -- Heritage Distribution Holdings (“HDH”), the U.S. platform for global HVAC/R wholesaler Beijer Ref, has signed an agreement to acquire AM Distributors, a well-established HVAC distributor serving contractors in the Greater Miami area. The company strengthens HDH’s presence in Florida.
Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 CongressesBOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational dual-targeted CD19/BCMA allogeneic CAR-T cell therapy for Systemic Lupus Erythematosus (SLE), at the European Alliance of Associations for Rheumatology 2026 Congress (EULAR) in London from June 3-6, 2026. Additionally, the company will showcase data on CTD402, its allogeneic CAR-T cell therapy candidate being developed for the treatment of relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL), at the European Hematology Association 2026 Congress (EHA) in Stockholm from June 11-14, 2026.
Two Babylonian Kings, an Egyptian Customs Official and a Corsican Hoard Lead TimeLine's 2 June Antiquities & Ancient Art AuctionDay One is the flagship sale with a dedicated printed catalogue; 3-8 June sessions are online-only; Coins, Weights, Tokens & Medals follow on 9-10 June.
SAIC Board of Directors Declares Cash DividendRESTON, Va., May 29, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (
NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 24, 2026 to stockholders of record on July 10, 2026.
DarkIris Announces Commercial Launch of AIGC Video Platform, video.aideptus.com, Integrating ByteDance’s Seedance 2.0 ModelHONG KONG, May 29, 2026 (GLOBE NEWSWIRE) -- DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), an innovative technology provider in the digital media and entertainment sector, today announced the commercial launch and global availability of its generative Artificial Intelligence-Generated Content (“AIGC”) video platform (the “Platform”), accessible at video.aideptus.com.
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that seven presentations, including four late-breaking abstracts, have been accepted for presentation at The Endocrine Society’s Annual Meeting (ENDO 2026) taking place June 13-16, 2026 in Chicago.
FOREWARN to Provide Identity Verification Services to Hawaii REALTORS® to Promote Agent SafetyHawaii REALTORS® contracts to make FOREWARN services available for its 10,000+ real estate professional members to promote proactive agent safety
Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T EfficacyLeveraging AI, trained on one of the industry’s largest clinical trial datasets, Medidata delivers quantifiable evidence to improve breast cancer trial enrollment and evaluate the efficacy of tocilizumab for CAR T-induced CRS
QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional InvestorNes Ziona, Israel, May 29, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a developer of additively manufactured electronics ("AME") technologies for cryogenic interconnect and quantum hardware infrastructure, today announced that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 6,666,667 ordinary shares (or ordinary share equivalents in lieu thereof) in a private placement. The gross proceeds from the offering are expected to be approximately $10 million, before deducting placement agent fees and other estimated offering expenses.
SunPower Achieves High NPS Score from StarbucksHigh NPS Milestone Reinforces Superior Product, Quality and Customer Success
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual MeetingData will highlight deeper mechanistic insights and long-term dosing potential of SAB-142, a fully human multi-specific ATG for newly diagnosed Stage 3 T1D
HomesToLife Delivers 36% Increase in Q1 2026 Net Profit to $3.2 Million on Export Growth and Stronger MarginsSINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Singapore-based home furniture company with sales across Asia-Pacific, Europe and North America, today announced its unaudited financial results for the quarter ended March 31, 2026 (“Q1 2026”).
Gentex Announces Second Quarter 2026 Cash DividendZEELAND, Mich., May 29, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (
NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable July 22, 2026, to shareholders of record of the common stock at the close of business on July 8, 2026.
Hammond Power Solutions Declares Quarterly DividendGUELPH, Ontario, May 29, 2026 (GLOBE NEWSWIRE) -- (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class B Common Share of HPS payable on June 17, 2026, to shareholders of record at the close of business on June 10, 2026. The ex-dividend date is June 10, 2026.
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDAWOBURN, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (
NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that following collaborative communications with the U.S. Food and Drug Administration (FDA), the Company and the FDA have aligned on a path forward for resubmission and reconsideration of the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma.
Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain TechnologyFunding to scale FDA-cleared Quicktome® platform and drive next-generation personalized brain care globally
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross ProceedsBRISBANE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the entry a definitive agreement for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,172,414 shares of the Company's common stock originally issued by the Company on November 26, 2025, having an original exercise price of $3.50 per share, at a reduced exercise price of $1.73 per share. The closing of the warrant exercise transaction is expected to occur on or about May 29, 2025, subject to satisfaction of customary closing conditions.
Li Auto Inc. Announces Results of Annual General MeetingBEIJING, China, May 29, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that each of the proposed resolutions submitted for shareholder approval (the “Proposed Resolutions”) as set forth in the notice of annual general meeting dated April 22, 2026 (the “AGM Notice”) has been adopted at its annual general meeting of shareholders held in Beijing, China today.
